课题基金 / 基金详情

Novel YcbQ Pili of Enterohemorrhagic E. coli O157:H7

Novel YcbQ Pili of Enterohemorrhagic E. coli O157:H7
肠出血性大肠杆菌O157:H7的新型YcbQ菌毛
批准号:
6862183
负责人:
JORGE A GIRON
金额:
$13.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-15 至 2008-02-28

项目摘要

项目成果

JORGE A GIRON的其他基金

相似基金

相关文献

中文摘要
翻译
性状(由申请方提供):肠出血性大肠杆菌。大肠杆菌(EHEC)O 157:H7被认为是一种重要的新兴病原体,可引起人类出血性结肠炎和溶血性尿毒综合征(HUS)。肠出血性大肠杆菌O 157:H7菌株产生了一种强效的滋贺毒素,与溶血尿毒综合征的发病机制有关。在O 157:H7菌株中尚未可重复地鉴定出皮利,因此,关于皮利是否在其天然牛或偶然人类宿主的肠道定殖中发挥作用仍然是一个谜。我们最近鉴定并纯化了EHEC菌株EDL 933和其他O 157:H7菌株产生的一种新的菌毛结构。这些皮利由18- kDa的菌毛蛋白亚基组成,其氨基末端显示出与EDL 933染色体中所含的ycbQ基因的预测产物的同一性。序列比较分析表明,这些皮利,在此称为YcbQ,属于由F17,K99和G皮利组成的毒力相关的皮利家族,在几种动物和人类致病性大肠杆菌中发现。大肠杆菌菌株和铜绿假单胞菌的CupA皮利。通过序列同源性分析,在EDL 933基因组中鉴定出4个与F17家族纤毛基因同源的基因(ycbQ,ycbR,ycbS,ycbT),其中ycbQ为结构基因。总的来说,本提案的目的是通过阐明EHEC O 157:H7粘附于培养中的人类上皮细胞的机制来推进对EHEC发病机制的认识。本研究将从分子生物学、细胞生物学、电镜超微结构分析、生化和抗原分析等多学科的角度,进一步研究EHEC O 157:H7与宿主靶细胞的相互作用。该建议的结果将为肠出血性大肠杆菌病的诊断和食品来源和水库中O 157:H7的检测提供重要的意义。所获得的信息对制定肠出血性大肠杆菌感染的预防和控制策略具有重要意义。该建议的中心焦点在于以下具体目标:1)确定YcbQ皮利生物发生所需的基因; 2)确定YcbQ皮利的作用;和3)研究ycb基因的转录表达。
英文摘要
DESCRIPTION (provided by applicant): Enterohemorrhagic E. coil (EHEC) O157:H7 is recognized as an important emerging pathogen responsible for producing hemorrhagic colitis and the hemolytic uremic syndrome (HUS) in humans. EHEC O157:H7 strains elaborate a potent Shiga toxin, which has been associated with the pathogenesis of HUS. No pili have yet been reproducibly identified in O157:H7 strains and therefore, it is still an enigma as to whether pili play a role in colonization of the intestine of their natural bovine or accidental human hosts. We have recently identified and purified a novel pilus structure produced by EHEC strain EDL933 and other O157:H7 strains. These pili are composed of an 18- kDa pilin subunit and its amino terminus shows identity to the predicted product of the ycbQ gene contained in the EDL933 chromosome. Sequence comparison analysis revealed that these pili, herein called YcbQ, belong to the virulence-associated pili family composed of F17, K99, and G pili found in several animal and human pathogenic E. coli strains, and CupA pili of Pseudomonas aeruginosa. Four genes (ycbQ, ycbR, ycbS, ycbT) with homology to F17 family piliation genes were identified by sequence homology in the genome of EDL933, being ycbQ the structural gene. Overall, the objective of this proposal is to advance knowledge of EHEC pathogenesis by elucidating the mechanism(s) of adherence of EHEC O157:H7 to human epithelial cells in culture. Several multidisciplinary approaches involving molecular biology, cell biology, ultrastructural analysis by high power electron microscopy, and biochemical and antigenic analysis will be carded out to extend our current knowledge on the interaction of EHEC O157:H7 with host target cells. The outcome of this proposal will provide important implications for diagnosis of EHEC disease and detection of O157:H7 in food sources and reservoirs. The information obtained will be important for prevention and control strategies of EHEC infections. The central focus of this proposal lies in the following specific aims: 1) To define the genes required for YcbQ pili biogenesis; 2) Define the role of YcbQ pili; and 3) Study transcriptional expression of ycb genes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting the role of fimbrial repertoire in Enteroaggregative Escherichia coli
  • 批准号:
    8823332
  • 项目类别:
  • 资助金额:
    $23.7万
  • 财政年份:
    2015
  • 负责人:
    JORGE A GIRON
  • 依托单位:
YagZ Pilus Adhesin of Attaching and Effacing E. coli
  • 批准号:
    7900663
  • 项目类别:
  • 资助金额:
    $6.79万
  • 财政年份:
    2006
  • 负责人:
    JORGE A GIRON
  • 依托单位:
YagZ Pilus Adhesin of Attaching and Effacing E. coli
  • 批准号:
    7665019
  • 项目类别:
  • 资助金额:
    $30.89万
  • 财政年份:
    2006
  • 负责人:
    JORGE A GIRON
  • 依托单位:
YagZ Pilus Adhesin of Attaching and Effacing E. coli
  • 批准号:
    7106096
  • 项目类别:
  • 资助金额:
    $33.42万
  • 财政年份:
    2006
  • 负责人:
    JORGE A GIRON
  • 依托单位:
国内基金
海外基金
Adhesin蛋白在铜绿假单胞菌中的致病功能及其机制研究
  • 批准号:
    2025JJ81015
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    宋静芳
  • 依托单位: